GE Aerospace's $368B Valuation Faces a 2.2% Cash Flow Reality Check
Analysis Daniel Marsh

GE Aerospace's $368B Valuation Faces a 2.2% Cash Flow Reality Check

GE Aerospace (NYSE:GE) shares fell 1.7% to $353.12, valuing the company at $368.4 billion. The stock trades at 44-46x guided free cash flow, implying a cash yield of just 2.2%.

GE RTX
SCHD Faces 17% Payout Hurdle to Sustain 9% Dividend Growth in 2026
Markets Daniel Marsh

SCHD Faces 17% Payout Hurdle to Sustain 9% Dividend Growth in 2026

SCHD must raise second-half distributions by 17.4% year-over-year to meet a 9% growth target for 2026, after first-half payments showed minimal change.

SCHD
Cramer Backs Walmart as Q2 Forecast Tests $642 Billion Valuation Gap
Markets Daniel Marsh

Cramer Backs Walmart as Q2 Forecast Tests $642 Billion Valuation Gap

Jim Cramer calls Walmart's recent dip an incredible buying opportunity. The retailer's Q2 forecast requires profit growth to outpace sales, while its $642B valuation gap highlights market bets on e-commerce and ad revenue.

WMT COST AMZN TGT
Chip Stocks Tumble as Korea's $576B AI Plan Sparks Supply Worry
Markets Daniel Marsh

Chip Stocks Tumble as Korea's $576B AI Plan Sparks Supply Worry

U.S. chip stocks dropped hard Monday as South Korea's massive AI investment plan and rising oil prices rattled supply outlooks, with memory and connectivity names leading losses.

MU SNDK TSM WDC ALAB ARM MRVL NVDA AMD SOXX SSNLF
Oil Majors and Refiners Surge as Fuel Margins Drive Earnings Boom
Commodities Rebecca Torres

Oil Majors and Refiners Surge as Fuel Margins Drive Earnings Boom

Oil majors and refiners saw strong gains as fuel margins, not just crude prices, drive Q2 earnings expectations. Exxon and Chevron combined adjusted net income is forecast at $25.8 billion.

XOM CVX MPC VLO USO
Costco's Low Churn Strategy Justifies Premium Valuation, RBC Says
Analysis Daniel Marsh

Costco's Low Churn Strategy Justifies Premium Valuation, RBC Says

Costco's low employee turnover and high membership renewal rates create a retention moat, but its 46.5x P/E ratio is a significant valuation hurdle, according to RBC Capital.

COST WMT BJ
Dow Falls 141 Points, but Two Stocks Drive Most of the Loss
Markets Daniel Marsh

Dow Falls 141 Points, but Two Stocks Drive Most of the Loss

The Dow fell 141 points, but Caterpillar and Goldman Sachs together cut 175 points, masking broader market flatness.

CAT GS CRM V IBM NVDA MU SNDK JPM
Narrow Tech Selloff Masks Broad Market Resilience as Rotation Plays Out
Markets Daniel Marsh

Narrow Tech Selloff Masks Broad Market Resilience as Rotation Plays Out

While the Nasdaq fell 0.9% on a memory-chip selloff, the equal-weight S&P 500 rose 0.18%, indicating the selling is narrow and a rotation into energy and defensive stocks is underway.

SPY QQQ SOXX XLE XLV CVX IBM UNH MORN MU SNDK NVDA TSM FDS
Oklo Stock Plunges 76%, Yet Pre-Revenue Firm Retains $5.4B Valuation
Markets Daniel Marsh

Oklo Stock Plunges 76%, Yet Pre-Revenue Firm Retains $5.4B Valuation

Oklo shares are down 76% from their 52-week high, but the pre-revenue nuclear company still commands a $5.4 billion valuation after accounting for its cash pile.

OKLO SMR NNE CEG META
CHPY Outperforms DRAM Amid Memory Selloff, But 62% of 2026 Payouts Were ROC
Markets Daniel Marsh

CHPY Outperforms DRAM Amid Memory Selloff, But 62% of 2026 Payouts Were ROC

CHPY fell 3.15% on Monday, outperforming DRAM's 8.23% slide, but 62% of its 2026 payouts were return of capital. DRAM's concentration in memory stocks drove the gap.

MU SSNLF NVDA
Ondas Shares Dip 2.3%, DZYNE Deal Value Falls $73 Million on Market Slide
Markets Daniel Marsh

Ondas Shares Dip 2.3%, DZYNE Deal Value Falls $73 Million on Market Slide

Ondas Inc. shares fell 2.3% to $7.09, cutting the value of shares issued to DZYNE sellers by $73 million. The deal's equity valuation now stands at 8.3x projected 2026 revenue.

ONDS KTOS AVAV
UnitedHealth Stock at $429: Earnings Test Looms as Investors Eye $25 EPS Target
Earnings James Calloway

UnitedHealth Stock at $429: Earnings Test Looms as Investors Eye $25 EPS Target

UnitedHealth stock trades up ahead of Q2 earnings, with the market pricing in a long-term EPS target of $25 by 2028. Analysts watch for margin improvements and Optum recovery.

UNH ELV CVS